Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of the anabolic androgenic steroid, nandrolone decanoate, on
substance P
endopeptidase-like activity was examined in adult male Sprague-Dawley rats.
Nandrolone decanoate
(15 mg/kg day) or oil vehicle (sterile arachidis oleum) were administered by intramuscular injections during 14 days.
Substance P
endopeptidase, a predominantly cytosolic enzyme, generates the bioactive N-terminal fragment
substance P
(1-7) from the enzyme substrate
substance P
.
Nandrolone decanoate
significantly reduced the
substance P
endopeptidase-like activity compared to control animals in hypothalamus (43% reduction), caudate putamen (44%), substantia nigra (32%) and the ventral tegmental area (27%). It was previously reported that both hypothalamus and caudate putamen contained significantly higher levels of
substance P
after nandrolone administration. The higher concentration of
substance P
in these regions could to an extent be attributed to the reduction in
substance P
endopeptidase-like activity. This result elucidates the important role of peptidase activity in the regulation of the
substance P
transmitter system. The present study provides additional support for the hypothesis that alterations in the
substance P
system in certain brain areas may contribute to some of the personality changes reported in connection with AAS abuse.
...
PMID:Administration of the anabolic androgenic steroid nandrolone decanoate affects substance P endopeptidase-like activity in the rat brain. 1609 48